A Phase 1 b/2 study to assess the safety, tolerability and efficacy of BGB-290 in combination with radiation therapy and/or temozolomide in subjects with first-line or recurrent/refractory

July 28, 2018
https://clinicaltrials.gov/ct2/show/NCT03150862
Cancer - Brain
Principal Investigator: Tobias Walbert, MD
Brain cancer, Recurrent cancer, glioblastoma, GBM
Accepting Participants